
Synopsys Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 86 trades in Synopsys Inc (NASDAQ: SNPS) since 2015, across 15 members, worth an estimated $1.1M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 35 buys against 49 sells, a modestly sell-led skew, with Democratic members responsible for 70% of the trades and Republican members 30%. The most recent disclosure shown was filed April 2026, and Ro Khanna has filed the most SNPS transactions among those shown, with 10. Other recent filers include Dan Newhouse, Gilbert Cisneros, and Michael T. McCaul. One notable disclosed move was a purchase by Lisa Mcclain on August 13, 2025, down 19.5% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Synopsys Inc (SNPS) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Synopsys congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | |
|---|---|---|---|---|---|---|---|
![]() Ro Khanna House | Apr 7, 2026 | Mar 30, 2026 | 8 days | SELL | $15,001 - $50,000 | +29.98% | |
![]() Ro Khanna House | Apr 7, 2026 | Mar 23, 2026 | 15 days | BUY | $1,001 - $15,000 | +15.15% | |
![]() Ro Khanna House | Mar 9, 2026 | Feb 24, 2026 | 13 days | BUY | $1,001 - $15,000 | +13.00% | |
![]() Ro Khanna House | Mar 9, 2026 | Feb 17, 2026 | 20 days | SELL | $1,001 - $15,000 | +18.03% | |
![]() Ro Khanna House | Mar 9, 2026 | Feb 5, 2026 | 32 days | SELL | $1,001 - $15,000 | +21.34% | |
![]() Ro Khanna House | Feb 6, 2026 | Jan 29, 2026 | 8 days | BUY | $1,001 - $15,000 | +3.75% | |
![]() Ro Khanna House | Feb 6, 2026 | Jan 13, 2026 | 24 days | BUY | $1,001 - $15,000 | -2.69% | |
![]() Dan Newhouse House | Jan 15, 2026 | Dec 31, 2025 | 15 days | BUY | $1,001 - $15,000 | +6.02% | |
![]() Gilbert Cisneros House | Dec 15, 2025 | Nov 18, 2025 | 27 days | SELL | $1,001 - $15,000 | +29.75% | |
![]() Ro Khanna House | Dec 8, 2025 | Nov 10, 2025 | 28 days | SELL | $15,001 - $50,000 | +24.27% |
Synopsys (SNPS) congressional trading FAQ
Can members of Congress legally trade Synopsys (SNPS) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Synopsys (SNPS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.
Are congressional Synopsys (SNPS) trades public?
Yes. Every congressional trade in Synopsys (SNPS) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Synopsys (SNPS)?
Members of Congress have disclosed 86 trades in Synopsys (SNPS) worth $1.1M across 15 members, according to public STOCK Act filings.
Which members of Congress have traded Synopsys (SNPS)?
Recent and active filers of Synopsys (SNPS) disclosures include Ro Khanna, Michael T. McCaul, Lisa Mcclain. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Synopsys (SNPS) more?
Across disclosed Synopsys (SNPS) trades, 70% were by Democrats and 30% by Republicans, led by Democrats (70%).
What is the most recent congressional Synopsys (SNPS) trade?
The most recent disclosed Synopsys (SNPS) trade was a purchase by Ro Khanna, filed Apr 6, 2026.
Browse all stocks Congress tradesCongressional trading overviewSynopsys (SNPS) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.


